Showing results (1751-1760 of 1,810) with videos related to

Sort By:
Pageof 181
Nature Communications|October 28, 2015
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelZhen Ning Wee, Siti Maryam J M Yatim, Vera K Kohlbauer, et al.
Eclinicalmedicine|November 13, 2023
A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional studyKun Zhao, Pindong Chen, Aaron Alexander-Bloch, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 28, 2020
Generalizable, Reproducible, and Neuroscientifically Interpretable Imaging Biomarkers for Alzheimer's DiseaseDan Jin, Bo Zhou, Ying Han, et al.
Chemical Science|February 16, 2024
Accessing metal-specific orbital interactions in C-H activation with resonant inelastic X-ray scatteringAmbar Banerjee, Raphael M Jay, Torsten Leitner, et al.
Biological Psychiatry|September 22, 2022
Four Distinct Subtypes of Alzheimer's Disease Based on Resting-State Connectivity BiomarkersPindong Chen, Hongxiang Yao, Betty M Tijms, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Human Brain Mapping|March 29, 2023
Altered large-scale dynamic connectivity patterns in Alzheimer's disease and mild cognitive impairment patients: A machine learning studyRixing Jing, Pindong Chen, Yongbin Wei, et al.
Nucleic Acids Research|March 17, 2023
The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesisZi Wang, Pan Wang, Jieying Zhang, et al.
Science Bulletin|January 20, 2023
ASAF: altered spontaneous activity fingerprinting in Alzheimer's disease based on multisite fMRIJiachen Li, Dan Jin, Ang Li, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
Pageof 181